JPRN-UMIN000048030已完成未知
Effects of tofogliflozin treatment on suppression of nocturia and promotion of urinary sodium excretion. - Effects of tofogliflozin treatment on suppression of nocturia and promotion of urinary sodium excretion.
Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine0 个研究点目标入组 36 人开始时间: 2022年6月11日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 2 diabetic patients who have an allergy against SGLT2 inhibitors 2) Type 2 diabetic patients who are pregnant
研究者
相似试验
已完成
不适用
Evaluation of Preventive Effect of tofogliflozin on cardiovascular function in type 2 diabetes with cardiovascular diseasestype 2 diabetes with cardiovascular diseaseJPRN-UMIN000018344tofogliflozin study group30
未知
1 期
Drug-drug interaction study (2) of TofoglifloziJPRN-jRCT2080221710Chugai Pharmaceutical Co., Ltd.87
招募中
4 期
Effect of tofogliflozin on pancreatic beta-cell functioType 2 diabetesJPRN-jRCTs011230006akamura Akinobu70
未知
1 期
Drug-drug interaction study (1) of TofoglifloziType 2 diabetsJPRN-jRCT2080221599Chugai Pharmaceutical Co., Ltd.90
未知
2 期
Clinical Pharmacology Study of Tofogliflozin --Evaluation of influence by degree of kidney functionType 2 diabetesJPRN-jRCT2080221532Chugai Pharmaceutical Co., Ltd.40